Drug
Formoterol clinical trials
Also written Foradil and Oxis.
- studies test it
- 179
- open now
- 7
- in phase 3
- 83
- first study started
- 2002
Keep track of what changes. Save the formoterol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
173 studies that test it; most in 2011 (13)
| Year | Studies |
|---|---|
| 2002 | 7 |
| 2003 | 4 |
| 2004 | 10 |
| 2005 | 11 |
| 2006 | 11 |
| 2007 | 7 |
| 2008 | 10 |
| 2009 | 8 |
| 2010 | 9 |
| 2011 | 13 |
| 2012 | 6 |
| 2013 | 7 |
| 2014 | 9 |
| 2015 | 12 |
| 2016 | 13 |
| 2017 | 8 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 12
- Phase 2
- 31
- Phase 3
- 83
- Phase 4
- 38
- No phase
- 14
What it is tested for
Each study’s main condition, where its own words name it.
- Asthma
- 68
Who runs them
Industry 124 · Other 55
AstraZeneca (50) · Dey (15) · Chiesi Farmaceutici S.p.A. (13) · Pearl Therapeutics, Inc. (13) · Sumitomo Pharma America, Inc. (4) · Zambon SpA (3) · Eurofarma Laboratorios S.A. (3) · Organon and Co (3)
Often tested with
Tested in the same studies.
Budesonide (77) · Glycopyrrolate (23) · Fluticasone (11) · Aclidinium (11) · Beclomethasone (10) · Aclidinium bromide (10) · Tiotropium (9) · Mometasone Furoate (6)
Studies
Open first, then newest update. How each study uses formoterol is read from its arms, and is right about nine times in ten.
Testing it · 179
- Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD)Not yet recruitingPhase 4University of Tennessee Graduate School of MedicineNCT07721922Written as formoterol fumarate
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseRecruitingPhase 3AstraZenecaNCT06283966Written as BGF MDI 320/14.4/9.6 μg
- A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and HyperinflationRecruitingPhase 4AstraZenecaNCT07073950Written as Budesonide/Glycopyrronium/Formoterol Fumarate
- Perioperative Inhaled Therapy in Carcinological Thoracic Surgery in Patients at High Risk of Postoperative Pulmonary ComplicationsRecruitingNot applicableCentre Hospitalier Universitaire, AmiensNCT06865040Written as Formoterol Fumarate 12 mcg (Foradil Aerolizer)
- Anti-Inflammatory Reliever South AfricaRecruitingPhase 3University of KwaZuluNCT06429475Written as Budesonide/formoterol
- Expertise Asthma COPD Program with Digital SupportRecruitingPhase 3Franciscus GasthuisNCT05831566Written as Budesonide/Formoterol fumarate dihydrate
- Evaluating Immunomodulatory Interventions in Post-Acute Sequelae of SARS-CoV-2 InfEctionNot yet recruitingNot applicableHuashan HospitalNCT06597682Written as Budesonide/Formoterol
- Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic PatientsCompletedPhase 2Zambon SpANCT02227394Written as Symbicort® Turbohaler®
- Extrafine ICS/LABA Versus As-Needed SABA for Small Airway Dysfunction in Symptomatic Patients With Preserved SpirometryCompletedPhase 4Yi-Han HsiaoNCT07809555Written as Beclomethasone dipropionate/formoterol fumarate (extrafine)
- Budesonide/Formoterol Inhalation Powder in Adults With AsthmaCompletedPhase 3Shanghai Xin Huanghe Pharmaceutical Co., Ltd.NCT07790159Written as Budesonide and Formoterol Fumarate
- ARrest RESpiraTory Failure From PNEUMONIATerminatedPhase 3Stanford UniversityNCT04193878Written as Inhaled budesonide and formoterol
- Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPDCompletedPhase 3Chiesi Farmaceutici S.p.A.NCT01917331Written as Beclometasone/Formoterol/Glycopyrrolate
- A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled CorticosteroidCompletedPhase 3Chiesi Farmaceutici S.p.A.NCT05292586Written as Beclomethasone Dipropionate/Formoterol Fumarate
- Sub-Sensitivity to Long-Acting Bronchodilators (LABA)CompletedNot applicableNational Jewish HealthNCT01117116Written as budesonide and formoterol
- Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)CompletedPhase 3AstraZenecaNCT04609904Written as BGF MDI 320/28.8/9.6 μg
- Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)CompletedPhase 3AstraZenecaNCT04609878Written as BGF MDI 320/28.8/9.6 μg
- Functional Respiratory Imaging Study (DARWiIN)CompletedPhase 3Chiesi Farmaceutici S.p.A.NCT04876677Written as Beclomethasone dipropionate/Formoterol Fumarate/Glycopyrronium (BDP/FF/GB)
- A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).CompletedPhase 3AstraZenecaNCT06067828Written as Treatment B: Budesonide and Formoterol Fumarate
- Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover StudyCompletedPhase 4Thammasat UniversityNCT06905483Written as Budesonide/Glycopyrronium/Formoterol (BGF)
- A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)CompletedPhase 3AstraZenecaNCT05202262Written as BFF MDI 320/9.6 μg
See all 179 studies that test formoterol →
Given in every arm · 15 — formoterol is usual care beside what is tested
- Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.Active, not recruitingPhase 3AstraZenecaNCT06473779Written as Budesonide/formoterol
- Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaActive, not recruitingPhase 2SanofiNCT06676319Written as Budesonide/Formoterol
- A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPDCompletedPhase 3Chiesi Farmaceutici S.p.A.NCT04320342Written as Formoterol Fumarate
- Study on Foster Efficacy Maintenance and Reliever vs Foster Maintenance + Salbutamol Reliever in Asthmatics (MART2)CompletedPhase 3Chiesi Farmaceutici S.p.A.NCT00861926Written as Beclomethasone dipropionate + Formoterol
- Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With AsthmaCompletedPhase 2SanofiNCT02573233Written as budesonide and formoterol
- A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPDCompletedPhase 3Mylan Inc.NCT03573817Written as Formoterol
- A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4GlaxoSmithKlineNCT03478696Written as budesonide/formoterol
- A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4GlaxoSmithKlineNCT03478683Written as budesonide/formoterol
- Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated AsthmaTerminatedPhase 4Novartis PharmaceuticalsNCT01912872Written as Formoterol
- Beta Blocker Therapy in Moderate to Severe COPDCompletedPhase 4University of DundeeNCT01656005Written as Beclometasone/formoterol
- Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible AsthmaCompletedPhase 3Mundipharma Research LimitedNCT01099722Written as Symbicort Turbohaler
- Small Airways Evaluation and TreatmentStatus unknownPhase 4Zhujiang HospitalNCT02526758Written as formoterol
- The Effects of Atorvastatin Treatment in COPD PatientsCompletedPhase 4Medical University of BialystokNCT01748279Written as Formoterol
- Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder InhalersCompletedPhase 1Orion Corporation, Orion PharmaNCT01668121Written as Symbicort Turbohaler
- Pharmacokinetic Pilot Study on Budesonide/FormoterolCompletedNot applicableOrion Corporation, Orion PharmaNCT01457716Written as Formoterol
As the comparator · 42 — what is tested is compared with formoterol
- Efficacy and Safety of CP006 Inhalation Powder in Participants With AsthmaCompletedPhase 2Shanghai Xin Huanghe Pharmaceutical Co., Ltd.NCT07807007Written as Budesonide and Formoterol Fumarate
- Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) (TRIVERSYTI)CompletedPhase 3Chiesi Farmaceutici S.p.A.NCT03197818Written as 160 µg budesonide + 4.5 µg formoterol fumarate
- ANTES B+ Clinical TrialTerminatedPhase 4Fundacio Privada Mon Clinic BarcelonaNCT06282861Written as Foradil
- Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent AsthmaCompletedPhase 3Chiesi Farmaceutici S.p.A.NCT00476268Written as Formoterol powder 12 µg/unit dose
- Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4)(COMPLETED)CompletedPhase 3Organon and CoNCT00383721Written as Formoterol MDI
- Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)(COMPLETED)CompletedPhase 3Organon and CoNCT00383435Written as Formoterol MDI
- Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®CompletedPhase 3Teva Branded Pharmaceutical Products R&D, Inc.NCT01803555Written as SYMBICORT® TURBOHALER®
- BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate)CompletedPhase 3Chiesi Farmaceutici S.p.A.NCT00929851Written as Formoterol fumarate
- A Study to Investigate the Differential Effects of Inhaled Symbicort and Advair on Lung MicrobiotaStatus unknownPhase 2University of British ColumbiaNCT02833480Written as Formoterol group
- A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent AsthmaCompletedPhase 3GlaxoSmithKlineNCT02446418Written as Formoterol Fumarate
- A Study to Show That Flutiform is Well Tolerated and Effective in the Treatment of COPDCompletedPhase 3Mundipharma Research LimitedNCT01946620Written as Formoterol
- An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible AsthmaCompletedPhase 3Mundipharma Research LimitedNCT00563056Written as Flixotide plus Foradil
- Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT)CompletedPhase 3Brigham and Women's HospitalNCT01290874Written as Formoterol
- Efficiency of Twice Daily Formoterol Versus Once Daily Tiotropium in Patients With GOLD A/B COPDStatus unknownNot applicableHuashan HospitalNCT03258749Written as Formoterol
- The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic VariationsTerminatedNot applicableBrigham and Women's HospitalNCT00706446Written as Formoterol
- Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 2Pearl Therapeutics, Inc.NCT01085045Written as Formoterol Fumarate 12 μg (Foradil® Aerolizer®)
- Efficacy of Indacaterol 150 µg Versus FormoterolWithdrawnPhase 4Novartis PharmaceuticalsNCT01377428Written as Formoterol
- Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic ChildrenCompletedPhase 2Chiesi Farmaceutici S.p.A.NCT01584492Written as Formoterol + Beclomethasone dipropionate
- Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and PlaceboCompletedPhase 2AstraZenecaNCT01049360Written as Formoterol 12 μg
- Efficacy and Safety of Two Fixed Dose Combinations of Aclidinium Bromide With Formoterol FumarateCompletedPhase 2AstraZenecaNCT01078623Written as Formoterol 12 μg
Showing 20 of 42.
Codes
What other systems call formoterol · ClinicalTrials.gg INT006538
- MeSH (NLM) D000068759Formoterol FumarateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 5ZZ84GCW8BFORMOTEROLConfirmed FDA, NLM, Wikidata
- Wikidata Q4789167arformoterolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65754FormoterolOne source FDA
- DrugBank DB01274One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000068759 | Formoterol Fumarate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 5ZZ84GCW8B | FORMOTEROL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q4789167 | arformoterol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65754 | Formoterol | One source FDA |
| DrugBank | DB01274 | — | One source Wikidata |
Also registered as arformoterol (UNII F91H02EBWT · RxNorm 304962) and formoterol fumarate (UNII W34SHF8J2K · RxNorm 998038).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.